These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 2805421

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anti-basement membrane antibodies in immunologic renal disease.
    Wilson CB, Holdsworth SR, Neale TJ.
    Aust N Z J Med; 1981; 11(Suppl 1):94-100. PubMed ID: 7020672
    [Abstract] [Full Text] [Related]

  • 24. [Anti-laminin and anti-type IV procollagen antibodies in Goodpasture's syndrome (author's transl)].
    Foidart J, Foidart J, Dubois C, Mahieu P.
    Nephrologie; 1980; 1(2):57-60. PubMed ID: 7301021
    [Abstract] [Full Text] [Related]

  • 25. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W, Liu Z, Ji D, Xie H, Gong D, Li L.
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
    Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
    [Abstract] [Full Text] [Related]

  • 30. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S, Boyce N, Thomson NM, Atkins RC.
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic immunoadsorption in Goodpasture disease].
    Moreso F, Poveda R, Gil-Vernet S, Carreras L, García-Osuna R, Griñó JM, Alsina J.
    Med Clin (Barc); 1995 Jun 10; 105(2):59-61. PubMed ID: 7603097
    [Abstract] [Full Text] [Related]

  • 32. Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome.
    Shoenfeld Y.
    Isr J Med Sci; 1996 Jan 10; 32(1):29-31. PubMed ID: 8550343
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Identification of Goodpasture target antigens in basement membranes of human glomeruli, lung, and placenta.
    Weber M, Köhler H, Manns M, Baum HP, Meyer zum Büschenfelde KH.
    Clin Exp Immunol; 1987 Feb 10; 67(2):262-9. PubMed ID: 3608225
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Glomerular basement membrane antibodies and immune complexes in a patient with Goodpasture's syndrome].
    Ratajczak T, Steciwko A, Cyba J, Weyde W.
    Pol Tyg Lek; 1980 Apr 14; 35(15):539-40. PubMed ID: 6447289
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome.
    Pasternack A, Törnroth T, Linder E.
    Clin Nephrol; 1978 Feb 14; 9(2):77-85. PubMed ID: 147761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.